PODCAST
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
All Episodes
00:33:37
00:21:40
00:18:45
01:04:02
00:14:43
01:08:01
GLP-1 Slow Responders: Dr Matthea Rentea // OTP Eps 108
On The Pen With Dave Knapp
·
2025/04/11
en-us
00:19:08
00:27:58
00:25:41
GLP-1 Medicare Coverage: What is Going On // OTP TWD...
On The Pen With Dave Knapp
·
2025/04/08
en-us
00:27:35
Are GLP-1 Meds For Life? Fractyl’s CEO Says “Not So...
On The Pen With Dave Knapp
·
2025/04/06
en-us
00:57:06
Fake Sugar: 👍 or 👎 for Weight Loss With Dr. Spencer...
On The Pen With Dave Knapp
·
2025/04/04
en-us
00:37:06
Tirzepatide Compounds: Lilly Sues Pharmacies // OTP...
On The Pen With Dave Knapp
·
2025/04/01
en-us
01:04:36
Zepbound Weight Loss Stalls: Tips and Tricks // OTP...
On The Pen With Dave Knapp
·
2025/03/29
en-us
00:32:20
Rare Exclusive Interview: OFA Chairman Sits Down with...
On The Pen With Dave Knapp
·
2025/03/26
en-us
00:27:37
00:53:14
Ozempic: Setting the Microdosing Strategy Straight w/...
On The Pen With Dave Knapp
·
2025/03/14
en-us
00:21:10
Compound Tirzepatide Latest // Cagrisema Disappoints...
On The Pen With Dave Knapp
·
2025/03/11
en-us
01:30:27
Obesity Bias in Medicine With Dr. Toomer // OTP Eps 104
On The Pen With Dave Knapp
·
2025/03/07
en-us
00:32:10
Compound GLP-1 Accessibility + World Obesity Day //...
On The Pen With Dave Knapp
·
2025/03/04
en-us
01:16:22